Literature DB >> 23510315

Medical characteristics of patients with macular telangiectasia type 2 (MacTel Type 2) MacTel project report no. 3.

Traci E Clemons1, Mark C Gillies, Emily Y Chew, Alan C Bird, Tunde Peto, Jie Jin Wang, Paul Mitchell, Wishal D Ramdas, Johannes R Vingerling.   

Abstract

PURPOSE: To determine whether the prevalences of various systemic conditions in participants of the MacTel Project Natural History Observation (NHO) Study differ from the corresponding prevalences in the general population.
METHODS: This report compares the prevalence of systemic disease in participants of the NHO Study with age- and sex-matched controls from three population-based studies from the US, the Netherlands and Australia. Bootstrap simulations were used to evaluate the impact and reliability of the computed statistics.
RESULTS: We identified a number of systemic conditions that appear to be more prevalent in cases with macular telangiectasia (MacTel) Type 2 than in the general population that were matched for age and sex with the MacTel cases. Patients with MacTel Type 2 had significantly increased prevalence of diabetes mellitus, higher prevalence of obesity, hypertension and history of cardiovascular disease, compared to their same-aged peers in generally older communities.
CONCLUSION: Systemic disease associated with MacTel Type 2 may help to improve understanding of possible causes of MacTel Type 2. It is hoped that future studies will help to improve our understanding of the pathogenesis of the condition and lead to potential treatments for this ocular disease.

Entities:  

Mesh:

Year:  2013        PMID: 23510315     DOI: 10.3109/09286586.2013.766757

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  17 in total

1.  Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.

Authors:  Daniel Pauleikhoff; Roberto Bonelli; Adam M Dubis; Frederic Gunnemann; Kai Rothaus; Peter Charbel Issa; Tjebo Fc Heeren; Tunde Peto; Traci E Clemons; Emily Y Chew; Alan C Bird; Ferenc B Sallo
Journal:  Acta Ophthalmol       Date:  2019-04-09       Impact factor: 3.761

2.  Genome-wide analyses identify common variants associated with macular telangiectasia type 2.

Authors:  Thomas S Scerri; Anna Quaglieri; Carolyn Cai; Jana Zernant; Nori Matsunami; Lisa Baird; Lea Scheppke; Roberto Bonelli; Lawrence A Yannuzzi; Martin Friedlander; Catherine A Egan; Marcus Fruttiger; Mark Leppert; Rando Allikmets; Melanie Bahlo
Journal:  Nat Genet       Date:  2017-02-27       Impact factor: 38.330

3.  LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.

Authors:  Tjebo F C Heeren; Diána Kitka; Daniela Florea; Traci E Clemons; Emily Y Chew; Alan C Bird; Daniel Pauleikhoff; Peter Charbel Issa; Frank G Holz; Tunde Peto
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

4.  Macular telangiectasia type 2 (MacTel) in a 34-year-old patient.

Authors:  Heleen Nicolai; Mieke Wirix; Leigh Spielberg; Anita Leys
Journal:  BMJ Case Rep       Date:  2014-09-23

5.  Serine and Lipid Metabolism in Macular Disease and Peripheral Neuropathy.

Authors:  Marin L Gantner; Kevin Eade; Martina Wallace; Michal K Handzlik; Regis Fallon; Jennifer Trombley; Roberto Bonelli; Sarah Giles; Sarah Harkins-Perry; Tjebo F C Heeren; Lydia Sauer; Yoichiro Ideguchi; Michelle Baldini; Lea Scheppke; Michael I Dorrell; Maki Kitano; Barbara J Hart; Carolyn Cai; Takayuki Nagasaki; Mehmet G Badur; Mali Okada; Sasha M Woods; Catherine Egan; Mark Gillies; Robyn Guymer; Florian Eichler; Melanie Bahlo; Marcus Fruttiger; Rando Allikmets; Paul S Bernstein; Christian M Metallo; Martin Friedlander
Journal:  N Engl J Med       Date:  2019-09-11       Impact factor: 91.245

6.  Global Connections to Study Idiopathic Macular Telangiectasia Type 2.

Authors:  Emily Y Chew; Martin Friedlander
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

7.  CONCURRENT IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2 AND CENTRAL SEROUS CHORIORETINOPATHY.

Authors:  Alexandre Matet; Suzanne Yzer; Emily Y Chew; Alejandra Daruich; Francine Behar-Cohen; Richard F Spaide
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

8.  A new CRB1 rat mutation links Müller glial cells to retinal telangiectasia.

Authors:  Min Zhao; Charlotte Andrieu-Soler; Laura Kowalczuk; María Paz Cortés; Marianne Berdugo; Marilyn Dernigoghossian; Francisco Halili; Jean-Claude Jeanny; Brigitte Goldenberg; Michèle Savoldelli; Mohamed El Sanharawi; Marie-Christine Naud; Wilfred van Ijcken; Rosanna Pescini-Gobert; Danielle Martinet; Alejandro Maass; Jan Wijnholds; Patricia Crisanti; Carlo Rivolta; Francine Behar-Cohen
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

9.  Serine biosynthesis defect due to haploinsufficiency of PHGDH causes retinal disease.

Authors:  Kevin Eade; Marin L Gantner; Joseph A Hostyk; Takayuki Nagasaki; Christian M Metallo; Martin Friedlander; Rando Allikmets; Sarah Giles; Regis Fallon; Sarah Harkins-Perry; Michelle Baldini; Esther W Lim; Lea Scheppke; Michael I Dorrell; Carolyn Cai; Evan H Baugh; Charles J Wolock; Martina Wallace; Rebecca B Berlow; David B Goldstein
Journal:  Nat Metab       Date:  2021-03-22

10.  Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes.

Authors:  Kerul Marsonia; Kedarisetti Kiran Chandra; M Hasnat Ali; Jay Chhablani; Raja Narayanan
Journal:  Semin Ophthalmol       Date:  2021-05-23       Impact factor: 2.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.